Imaging of Adrenal Incidentalomas and Their Mimics: A Practical Update for Risk Stratification and Management from a Precision Imaging Perspective
Authors:
- Francesco TiralongoFTFrancesco Tiralongo
- Miriam AdornaMAMiriam Adorna
- Chiara PaternòCPChiara Paternò
- Sebastiano BarbarinoSBSebastiano Barbarino
- Dario MilazzoDMDario Milazzo
- Cristina MosconiCristina Mosconi
- Sandro La VigneraSandro La Vignera
- Corrado Ini’CICorrado Ini’
- Davide Giuseppe CastiglioneDCDavide Giuseppe Castiglione
- Roberto MiniciRoberto Minici
- Emanuele DavidEDEmanuele David
- Pietro Valerio FotiPFPietro Valerio Foti
Open Access
- 19 October 2026
- journal article
- review article
- Published by MDPI AG in Endocrines
- Vol. 7 (4) , 63
Abstract
Background/Objectives: To provide an updated overview of adrenal incidentaloma evaluation, characterize the principal imaging mimics across pediatric and adult populations, and propose a clinically actionable approach integrating endocrine assessment with conventional and advanced imaging. Methods: A narrative review of recent evidence and major international recommendations was performed, focusing on epidemiology, endocrine work-up, non-contrast computed tomography (CT), washout CT, magnetic resonance imaging (MRI), and dual-energy CT (DECT). Results: The recent literature has questioned a uniformly washout-centered approach and has raised interest in more selective, risk-adapted strategies based on clinical context, endocrine profile, and lesion phenotype; however, these proposals should be distinguished from established guideline recommendations. Non-contrast CT remains the cornerstone of first-line characterization, particularly for identifying lipid-rich adenomas. However, the routine use of adrenal washout CT is increasingly questioned, especially in true incidentalomas, because many benign adenomas are lipid-poor and several non-adenomatous lesions may show overlapping washout behavior. In this setting, MRI maintains a key problem-solving role, mainly through chemical shift imaging. DECT represents the most promising technical advance, enabling multiparametric characterization through virtual non-contrast images, iodine quantification, and material decomposition, with the potential to improve the assessment of indeterminate lesions while reducing unnecessary multiphasic imaging and radiation exposure. Conclusions: Current management should remain grounded in established guideline recommendations. MRI may be selectively used as a problem-solving modality, while DECT and emerging strategies require further validation before they can be considered standards of care.Keywords
This publication has 136 references indexed in Scilit:
- Quantitative PCCT imaging in differentiating adrenal adenomas from metastases: diagnostic performance and its clinical applicationsAbdominal Radiology, 2025
- Non-contrast spectral CT vs chemical-shift MRI in discriminating lipid-poor adrenal lesionsEuropean Radiology, 2024
- Diagnostic performance of photon-counting detector CT for differentiation between adrenal adenomas and metastasesEuropean Radiology, 2024
- Evaluation of the T2-weighted (T2W) adrenal MRI calculator to differentiate adrenal pheochromocytoma from lipid-poor adrenal adenomaEuropean Radiology, 2022
- Volume-outcome correlation in adrenal surgery—an ESES consensus statementLangenbeck's Archives of Surgery, 2019
- Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimicsAbdominal Radiology, 2019
- Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysisEuropean Radiology, 2018
- Bilateral adrenal abnormalities: imaging review of different entitiesAbdominal Radiology, 2018
- Pheochromocytoma as a frequent false-positive in adrenal washout CT: A systematic review and meta-analysisEuropean Radiology, 2017
- The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imagingEuropean Radiology, 2014